Neutralization of HSF1 in cells from PIK3CA-related overgrowth spectrum patients blocks abnormal proliferation
Romain Da Costa(Fondation Asile des Aveugles), Gaëtan Jégo(Inserm)
Cited by 16
Related Papers
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma
|Journal of Experimental & Clinical Cancer Research|2024|7